Patents by Inventor David Burgin

David Burgin has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • HYBRID NEUROTOXINS
    Publication number: 20210277071
    Abstract: The present invention relates to hybrid neurotoxins comprising a clostridial light chain and a selective ganglioside binding moiety and to their use in therapy.
    Type: Application
    Filed: September 28, 2017
    Publication date: September 9, 2021
    Inventors: Elena FONFRIA-SUBIROS, David BURGIN
  • Chimeric polypeptides
    Patent number: 10648045
    Abstract: Chimeric clostridial neurotoxins in which the activation loop has been replaced by an activation loop from a different subtype within the same serotype. Methods of producing, activating, and using such neurotoxins. Compositions comprising such neurotoxins. Polynucleotides, vectors and cells for expressing such neurotoxins.
    Type: Grant
    Filed: March 22, 2016
    Date of Patent: May 12, 2020
    Assignee: IPSEN BIOPHARM LIMITED
    Inventors: Daniel Kwan, David Burgin, Stephen Gavin Hackett